Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Therapeutic monoclonal mntibodies: where have we come and where are we going?

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: SCANNON, Patrick (XOMA Corporation, Chief Scientific Officer, Berkeley, california, United States of America)
  • Abstract:

    Publication in 1975 by Köhler and Milstein of methods for making monoclonal antibodies (mAbs) has resulted in a new drug class and correspondingly, a new global industry. This class of targeted therapeutics has substantially grown both in product numbers and total drug market share.
    The growth of this market was initially limited by two..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses